Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
N/A
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$4.01M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
64.44%
5Y Avg
-64.28%
Market Cap
$4.34M
Net Profit Margin
0.00%
TTM Avg
-3826.38%
3Y Avg
-9879.36%
5Y Avg
-6586.24%
Market Cap
$4.43M
Net Profit Margin
-3934.91%
TTM Avg
-1854.81%
3Y Avg
-2358.55%
5Y Avg
-1587.79%
Market Cap
$4.55M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.53M
Net Profit Margin
-105.71%
TTM Avg
-81.70%
3Y Avg
-1471.40%
5Y Avg
-1177.12%
Market Cap
$4.65M
Net Profit Margin
-285.00%
TTM Avg
-249.81%
3Y Avg
-232.15%
5Y Avg
-165.63%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRI Bio, Inc. (GRI) | $4.13M | N/A | 0.00% | 0.00% | 0.00% |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.01M | 0.00% | 0.00% | 64.44% | -64.28% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.34M | 0.00% | -3826.38% | -9879.36% | -6586.24% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | -3934.91% | -1854.81% | -2358.55% | -1587.79% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| Moolec Science S.A. (MLEC)vs › | $3.53M | -105.71% | -81.70% | -1471.40% | -1177.12% |
| Eocene Ltd. (EOCN)vs › | $3.70M | N/A | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.65M | -285.00% | -249.81% | -232.15% | -165.63% |
| Mustang Bio, Inc. (MBIO)vs › | $3.56M | 0.00% | 0.00% | 0.00% | 0.00% |
| Evogene Ltd. (EVGN)vs › | $3.41M | -694.19% | -257.90% | -726.73% | -1357.15% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | -1161.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
